Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 370.95
+2.90 (0.79%)
Nov 12, 2026, 3:29 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 604.02 billion as of November 12, 2026. It is the 3,018th most valuable company in the world and the 180th biggest in India. Its market cap has increased by 17.54% in one year.
Market Cap
604.02B
Enterprise Value
757.26B
Revenue
174.15B
Global Rank
Country Rank
#180 India
PE Ratio
126.18
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 604.02B, an increase of 1,230.05%. That is a compound annual growth rate of 12.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 604.02B | 14.91% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 539.48B |
| OneSource Specialty Pharma | 181.47B |
| Concord Biotech | 124.91B |
| Blue Jet Healthcare | 101.28B |
| Supriya Lifescience | 51.43B |
| Zota Health Care | 46.06B |
| Dishman Carbogen Amcis | 27.44B |
| Panacea Biotec | 21.61B |